about
Neurophysiologic and neuroimaging studies of brain plasticity in children with spastic cerebral palsy.Identification of demographic factors and health problems that affect the acceptance of disease and health behaviors of patients with osteoarthritisAcceptance of illness and satisfaction with life among malaria patients in rivers state, Nigeria.Duchenne muscular dystrophy: current cell therapiesIsolation frequency of Candida present on the surfaces of mobile phones and handsx.Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies.Evaluation of quality of life in chronic, progressing rheumatic diseases based on the example of osteoarthritis and rheumatoid arthritis.Retrospective observation of drug susceptibility of Candida strains in the years 1999, 2004, and 2015.Assessment of risk factors for osteoporosis and fractures in children with meningomyelocele.Annual variations of quantitative EEG in patients with chronic epilepsy.A comparison of the perceptions and aspirations of third-year physiotherapy students trained in three educational settings in Poland.Comparison of the Results of Studies of Air Pollution Fungi Using the SAS Super 100, MAS 100, and Air IDEAL.Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.Dysphagia in children with infantile cerebral palsy.Somatosensory evoked potentials in epileptic children treated with carbamazepine or valproate in monotherapy - a preliminary study.Recombinant granulocyte colony-stimulating factor increases muscle strength in neuromuscular disorders.Psychometric properties and validation of the Polish CP QOL-Child questionnaire: a pilot study.Proton magnetic resonance spectroscopy in children with spastic diplegia.Efficacy and the Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Muscular Dystrophy: A Non-Randomized Clinical Trial.An age and gender dependency of metabolite concentrations in basal ganglia in children with spastic diplegia: proton magnetic resonance spectroscopy study.Antioxidant enzymes and lipid peroxides in children with cerebral palsy.Corpus callosum size in children with spastic cerebral palsy: relationship to clinical outcome.Spastic cerebral palsy: clinical magnetic resonance imaging correlation of 129 children.Risk factors and prognosis of epilepsy in children with cerebral palsy in north-eastern Poland.Somatosensory and visual evoked potentials in children with cerebral palsy: correlations and discrepancies with MRI findings and clinical picture.Metabolite alterations in autistic children: a 1H MR spectroscopy study.Quality of life in children and adolescents with cerebral palsy and myelomeningocele.Clinical and neuroimaging profile of congenital brain malformations in children with spastic cerebral palsy.A comparison of spastic diplegic and tetraplegic cerebral palsy.Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating FactorAnticonvulsive properties of calcitonin in ratsEvaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsyImpression cytology of the conjunctival epithelial cells in patients with cystic fibrosisComparisons of right and left hemiparetic cerebral palsySchizencephaly as a cause of spastic cerebral palsyAnti-inflammatory plasma cytokines in children and adolescents with migraine headachesRisk factors for cerebral palsy in term birth infantsUse of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsyProton magnetic resonance spectroscopy in patients with normal pressure hydrocephalusSerum 25-hydroxyvitamin D, osteocalcin, and parathormone status in children with meningomyelocele
P50
Q31029748-924CE53B-08EF-4B97-B62C-7F5A63004142Q33645145-3A8ACB32-427B-468C-92EC-F9902135D0CFQ33712620-EFCDEA71-D7F5-4443-BFE5-0322378AE324Q35780806-2AC1AD60-6690-459F-94C3-08286E050DF9Q36035842-0FAA7E57-E657-4662-925B-F33EE7621C40Q36386715-C8373736-6BD2-4EC6-996D-9BF78DFBD334Q37468640-D5A15DC2-731E-4401-9530-AC3709CED6EAQ37666788-7BE4274F-7084-40E9-A5F2-A66A6741EAA5Q38490997-C5416061-3537-4B5D-BF30-0FC5858B3AB1Q39866795-217F00DC-49F3-44BD-8FB4-FF71F61FA9DBQ39905226-F9BB0D98-BFAF-45ED-B4E1-C5C07AF0F265Q41339095-16D881D0-4FE6-443E-AE18-41268236CE6DQ42754395-C8DA155D-E8E3-4B9F-BC24-0091C9BB3BA2Q42863425-9B240DC8-C5A9-4A14-965D-36AFECC12A01Q43049785-DFA3D48B-D499-486C-A377-70F94B9ABC7AQ43466147-0CE0F4DC-DB39-4403-8F08-DAC5B3D85F55Q44501470-C153D473-08F5-4C39-821A-4B7112B662B0Q44906350-8353B7E8-F177-4CFD-A732-6BC34C8CEA54Q45203621-85F60198-3748-4A98-BB44-2EDB7DD8B6F6Q46308365-03FF17DE-24CC-4936-BE37-58B8D742792DQ46566716-1C77715A-B887-4C28-B0F6-B3DEF3A41ACFQ47280379-A8D6523C-2B68-4F5B-A211-0D57AA854E24Q48117974-6E0837CD-DEED-4D31-A564-D00E9F4A1266Q48197536-EFE88136-45EC-4C41-9540-4FBF2E1AEF80Q48393004-D6BF5418-6825-4B7C-90A4-9C0AE9E50AA3Q48585893-D7E0250F-081F-4B30-A91B-6BF1D5222804Q48615697-7A258810-BC8F-4E15-AE0F-3DCCF30A4C90Q51890986-C6EC0E49-DA3E-4132-8AD4-5511BCFD28FBQ51930536-6BB3239D-5AC6-45FC-BA9E-1AE56781A868Q64096746-D197256F-F6E4-4E49-8883-6668AF56D6F1Q67997476-4F619BA7-C964-495B-872C-8B60E9CD3F29Q80257055-A4743EC0-542F-4A34-A9DA-EA11F8B1278EQ80382815-DD1B9056-3D0B-49E7-B1C1-F0D5AC8D806CQ80431006-DA8ABEF0-0F16-49F6-BD32-7B33F41D55CAQ83737486-2F3F7266-055C-4024-97B1-0D6D129F5F06Q84318007-9AF734B2-4121-4B32-B1F3-1E31B1B92AB1Q84676538-AD47FFCA-2530-4904-A54D-E9318399A559Q85215431-3C4C463B-AB76-4655-9228-A484DF4DCF9CQ86973701-7B85EE00-6073-409E-9A1B-CBD75A9B77CCQ87370868-1967AC06-1417-4CC5-B40E-608169577B1C
P50
description
researcher ORCID ID = 0000-0003-1118-9139
@en
wetenschapper
@nl
name
Wojciech Kułak
@ast
Wojciech Kułak
@en
Wojciech Kułak
@es
Wojciech Kułak
@nl
type
label
Wojciech Kułak
@ast
Wojciech Kułak
@en
Wojciech Kułak
@es
Wojciech Kułak
@nl
prefLabel
Wojciech Kułak
@ast
Wojciech Kułak
@en
Wojciech Kułak
@es
Wojciech Kułak
@nl
P106
P1153
6603573997
P31
P496
0000-0003-1118-9139